4AB:FRA
AbbVie Common Stock
€260.10
arrow_upward
+0.66%(+1.70) 1D
Nov 4, 12:33:28 PM GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4AB...
Open
€254.40
High
€260.10
Low
€254.40
Mkt. cap
505.40B
Avg. vol.
114.00
Volume
20.00
52-wk high
€272.30
52-wk low
€167.55
No. of employees
57K
Open
€254.40
High
€260.10
Low
€254.40
Mkt. cap
505.40B
Avg. vol.
114.00
Volume
20.00
52-wk high
€272.30
52-wk low
€167.55
No. of employees
57K
News stories
From web sources and news partners
Yahoo Finance
·
1 hour ago
AbbVie bolsters UK R&D presence, inks $1.38bn IBD deal with Nxera
PMLiVE
·
2 hours ago
AbbVie expands Oxford R&D as part of more than £120m investment in UK life sciences
Reuters
·
14 hours ago
AbbVie expands Oxford R&D facility as part of £120 million-plus investment
TradingView
·
19 hours ago
AbbVie 2026: Revenue $17.4B, Net income $4.22B, EPS $2.37— 10-Q Summary
Profile
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues.
The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and 108th on the Forbes Global 2000. The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'. Wikipedia
About AbbVie Common Stock
CEORobert A. Michael
Employees57K
FoundedApr 10, 2012
HeadquartersNorth Chicago, Illinois, United States
SectorBiotechnology
Industry-
Websiteabbvie.com